Digital Health Fundamental Analysis

Digital Health Overview

Digital health market, driven by over $9 billion in funding across 160 companies having over 400 solutions, is likely to grow rapidly in the coming decade. These investments are likely to grow rapidly in the coming decade, driven by approval, reimbursement and acceptance of digital therapeutics for disease treatment as well as management.

Tap or click on the images for smart insights on Digital Health Market

Digital therapeutics are clinically validated solutions that are delivered as applications, software and online programs, demonstrating the capability to facilitate positive outcomes when employed in the management of clinical conditions. These therapeutics are designed to engage patients in personalized treatment or disease prevention programs, through mediating behavioral or psychological modifications.

Tap or click on the images for smart insights on Digital Health Market

Currently, a wide variety of digital health applications and intuitive software are available for the aforementioned purposes. In fact, the COVID-19 pandemic has created a significant demand for remote healthcare solutions. Amidst other alternatives, digital therapeutics have emerged as a promising option since these can be employed as preventive or curative digital solutions for managing diverse target indications.

Tap or click on the images for smart insights on Digital Health Market

A recent survey highlighted that the percentage of patients adopting digital therapeutics in the US rose from 4.7% to 18%, post the pandemic outbreak, resulting in an increased prescription rate of such therapeutics. Further, taking into consideration both the historical and contemporary scenarios, we believe that the digital therapeutics market presents lucrative investment opportunities for both short and long term investors.

Recent Funding and Investment in Digital Health Companies

Several investments have taken place in the field of digital health, and we outline some of these below.

• In April 2025, Click Therapeutics raised USD 48.5 million in an equity funding.
• In February 2025, CareLoop raised GBP 1.8 million in a funding round co-led by GMC Life Sciences Fund by Praetura and Verge HealthTech Fund.
• In January 2025, Allara Health, a women’s digital health company, raised USD 26 million in a Series B funding round led by Index Ventures. The company offers a virtual care platform for hormonal conditions including endometriosis, polycystic ovarian syndrome (PCOS) and hypothyroidism.

Women’s Digital Health Fundamental Analysis: Report Deliverables

Women’s Digital Health Fundamental Analysis Major Takeaways

The “Investor Series: Opportunities in Digital Health Market” market report provides detailed information on the digital therapeutics market, covering the core and peripheral digital therapeutics solutions. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of future business success, over the coming decade. Key takeaways of the market report are briefly discussed below.

What Are Some Approved Digital Health Solutions?

Presently, there are more than 40 USFDA approved digital therapeutic solutions available in the market, including apps, software and devices, for the management of numerous therapeutic areas, such as mental health disorders, substance use disorders and reproductive health.

It is worth noting that reSET, developed by Pear Therapeutics, was the first prescription digital therapeutics that received the USFDA approval in 2017. The application can be used as a method of opioid replacement therapy, increasing a patient's abstinence from substances of abuse during the treatment and enhancing the outpatient treatment program retention.

The most recent FDA approval was received by Click Therapeutics for its prescription digital therapeutic CT-132 for preventive treatment of episodic migraine in April 2025.

How Has the Funding Shaped the Digital Health Industry Growth?

Owing to the increased adoption rate of digital solutions and rise in the demand for remote healthcare services, the companies involved in the digital therapeutics domain have witnessed a surge in the investment activity, with capital investments worth more than USD 9 billion. According to the recent trends, various digital therapeutic companies are engaged in providing personalized solutions, along with remote access to medical care facilities, including a health coach.

What are the Growth Drivers for Investment in Digital Health Industry?

The primary benefits of digital therapeutics include reduction of treatment related costs, generation and maintenance of personalized health data, reduction in stress amongst healthcare professionals, and increase in the adherence to prescribed treatment regimens. In addition, these digital health solutions provide motivational support and inculcate healthy lifestyle changes in the target patient population.

Scope of the Digital Health Fundamental Analysis

The market report presents an in-depth analysis, highlighting the digital health industry financials. Amongst other elements, the market report includes:

• A qualitative and quantitative (wherever information was available) perspective on the current need for digital therapeutics, highlighting some of the key applications of such offerings. Further, it highlights various challenges faced during stages of drug discovery, and the opinions of representatives from key stakeholder companies involved in this domain.
• A detailed analysis of digital therapeutics focused companies that were established post 2005, featuring inputs on observed trends related to basic input parameters, such as year of establishment, location of headquarters, company size, and type of venture.
• A quantitative perspective on the relative health (based on basic company details, product details, financing activity, and estimated revenues and profits) of the different innovator companies that have been described in detail in this report. This analysis is based on a proprietary scoring criterion, informed via secondary research.
• An assessment of the various solutions, offered by the companies mentioned above, featuring analysis based on number and types of products, and an informed perspective on the value of the offerings based on multiple relevant aspects, namely outreach-related value offered, developer-related value, value to patients and product-related value.
• A company competitiveness analysis, which offers a quantitative basis for comparing the strengths / contributions of various industry stakeholders that are involved in providing digital therapeutic solutions, captured in this report. It is worth mentioning that this analysis is based on the insights generated from the abovementioned relative health indexing and value proposition analyses.
• A detailed analysis of the funding and investment activity that has taken place in this domain, since 2011. It also includes financing category-wise trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the innovator companies discussed in the report. Further, it features a list of the leading investors in digital therapeutics, based on their participation in financing activity in this industry segment.
• An elaborate review of the overall digital therapeutics market from a financial perspective, including detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of the publicly listed companies within the market landscape dataset.
• A business risk analysis, based on some of the major categories of risk that are usually discussed in the industry, namely operations-related risks, overall business-related risks, financial risks, product / technology associated risks, and social, economic, environmental and political risks.
• Case studies of instances where investors have exited various digital therapeutics related ventures, offering insights on return on investments made (based on availability of data). Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the digital therapeutics market.
• A key acquisition targets analysis, based on the insights generated during the course of this study, highlighting some of the promising early-to-mid stage business ventures around which there is likely to be interest for future acquisitions / mergers.